Intravenous dexmedetomidine pre-medication reduces the required minimum alveolar concentration of sevoflurane for smooth tracheal extubation in anesthetized children: a randomized clinical trial

Table 1 Patient data and clinical characteristics

Variable	Group D₀ (n = 25)	Group D₁ (n = 26)	Group D₂ (n = 24)
Age (y)	5.3 ± 1.3	5.0 ± 1.1	5.1 ± 1.0
Sex (male/female)	12/13	13/13	13/11
Weight (kg)	19.5 ± 3.4	19.6 ± 3.7	19.8 ± 3.4
Duration of surgery (min)	18.5 ± 3.4	19.3 ± 3.4	18.6 ± 4.0
Duration of anesthesia (min)	32.8 ± 3.7	34.4 ± 4.0	33.9 ± 4.1
Time from initiation of dexmedetomidine/saline infusion to tracheal removal (min)	47.0 ± 3.6	46.6 ± 4.0	47.2 ± 4.5

Data are expressed as mean ± standard deviation (SD) (One-way ANOVA test) or number of patients (Chi Square test)
Group D₀ = saline group, Group D₁ = dexmedetomidine group (1 μg·kg⁻¹), Group D₂ = dexmedetomidine group (2 μg·kg⁻¹)

ISSN: 1471-2253